Rozanolixizumab
Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].
Product Specifications
CAS Number
1584645-37-3
Product Name Alternative
UCB7665
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rozanolixizumab.html
Purity
99.40
Solubility
H2O
Smiles
[Rozanolixizumab]
Molecular Weight
(145.242 kDa)
References & Citations
[1]Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10 (7) :1111-1130.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1582008 1.0 µg DNA
P2RY1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
bs-9409R-PE-Cy5.5 100 µL
RNF9 Polyclonal Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details 